URGNUroGen Pharma Ltd.
$34.54+104% 1Y
$34.54
$16.9552 weeks$50.29
Is the price fair?
What URGN's price assumes
UroGen Pharma Ltd. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 8.95× revenue.
8.95
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 9.37
EV / sales
Details›
- EV / EBIToperating margin −35%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 9.37
- Market capitalisation48.9 million shares, counted Jul 28, 2026
- $1.69B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks